Endovascular management of aorto-iliac occlusive disease (Leriche syndrome)

Huei-Lung Liang1, Ming-Feng Li1, Chia-Chi Hsiao1

  • 1Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC; Department of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung City, Taiwan, ROC.

Insights

Endovascular therapy offers a high success rate for chronic aorto-iliac occlusive disease, providing a viable alternative to surgery for high-risk patients with excellent patency rates.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Interventions

Background:

  • Chronic aorto-iliac occlusive disease (AIOD), also known as Leriche Syndrome, traditionally treated with bypass grafting.
  • Surgical re-intervention for AIOD carries significant mortality risks (up to 25%).
  • Limited reports exist for endovascular strategies in Leriche Syndrome, despite a trend towards endovascular approaches for TASC II C and D lesions.

Purpose of the Study:

  • To evaluate the efficacy and safety of endovascular therapy for chronic aorto-iliac occlusive disease in high-risk patients.
  • To assess technical success, complication rates, and patency outcomes of endovascular treatment for AIOD.
  • To determine if endovascular therapy is a suitable alternative to surgical intervention for this patient population.

Main Methods:

  • Retrospective review of 15 high-risk patients with chronic AIOD.
  • Utilized retrograde approaches (femoral arteries) for shorter occlusions and antegrade approaches (brachial artery) for juxtarenal lesions.
  • Employed intraluminal or subintimal angioplasty with stent or stent-graft deployment, including kissing-stent techniques.

Main Results:

  • 100% technical success in treating 28 iliac arteries and 14 occluded abdominal aortas.
  • Subintimal technique contributed to 25% of successful treatments.
  • Two minor complications (vascular rupture, distal emboli) were managed endovascularly; no renal artery emboli occurred.
  • Primary patency rates: 92.3% (1 yr), 83.9% (3 yrs), 83.9% (5 yrs). Secondary patency rates: 100% (1, 3, and 5 yrs).

Conclusions:

  • Endovascular therapy demonstrates high technical success for chronic AIOD.
  • Achieved favorable short- and mid-term primary and secondary patency rates.
  • Represents a potentially valid alternative to surgical intervention for high-risk patients with AIOD.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
132
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
135
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
203
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
194
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
143
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
177